A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens
ABSTRACT Group 2 capsule polymers represent crucial virulence factors of Gram-negative pathogenic bacteria. They are synthesized by enzymes called capsule polymerases. In this report, we describe a new family of polymerases that combine glycosyltransferase and hexose- and polyol-phosphate transferas...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6c00b5c8ad3940f2af66b90fac7376c3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6c00b5c8ad3940f2af66b90fac7376c3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6c00b5c8ad3940f2af66b90fac7376c32021-11-15T16:00:25ZA New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens10.1128/mBio.00641-182150-7511https://doaj.org/article/6c00b5c8ad3940f2af66b90fac7376c32018-07-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00641-18https://doaj.org/toc/2150-7511ABSTRACT Group 2 capsule polymers represent crucial virulence factors of Gram-negative pathogenic bacteria. They are synthesized by enzymes called capsule polymerases. In this report, we describe a new family of polymerases that combine glycosyltransferase and hexose- and polyol-phosphate transferase activity to generate complex poly(oligosaccharide phosphate) and poly(glycosylpolyol phosphate) polymers, the latter of which display similarity to wall teichoic acid (WTA), a cell wall component of Gram-positive bacteria. Using modeling and multiple-sequence alignment, we showed homology between the predicted polymerase domains and WTA type I biosynthesis enzymes, creating a link between Gram-negative and Gram-positive cell wall biosynthesis processes. The polymerases of the new family are highly abundant and found in a variety of capsule-expressing pathogens such as Neisseria meningitidis, Actinobacillus pleuropneumoniae, Haemophilus influenzae, Bibersteinia trehalosi, and Escherichia coli with both human and animal hosts. Five representative candidates were purified, their activities were confirmed using nuclear magnetic resonance (NMR) spectroscopy, and their predicted folds were validated by site-directed mutagenesis. IMPORTANCE Bacterial capsules play an important role in the interaction between a pathogen and the immune system of its host. During the last decade, capsule polymerases have become attractive tools for the production of capsule polymers applied as antigens in glycoconjugate vaccine formulations. Conventional production of glycoconjugate vaccines requires the cultivation of the pathogen and thus the highest biosafety standards, leading to tremendous costs. With regard to animal husbandry, where vaccines could avoid the extensive use of antibiotics, conventional production is not sufficiently cost-effective. In contrast, enzymatic synthesis of capsule polymers is pathogen-free and fast, offers high stereo- and regioselectivity, and works with high efficacy. The new capsule polymerase family described here vastly increases the toolbox of enzymes available for biotechnology purposes. Representatives are abundantly found in human pathogens but also in animal pathogens, paving the way for the exploitation of polymerases for the development of a new generation of vaccines for animal husbandry.Christa LitschkoDavide OldriniInsa BuddeMonika BergerJochen MeensRita Gerardy-SchahnFrancesco BertiMario SchubertTimm FiebigAmerican Society for MicrobiologyarticleTagFcapsular polysaccharidecapsuleenzymatic synthesisnuclear magnetic resonancepolymerasesMicrobiologyQR1-502ENmBio, Vol 9, Iss 3 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
TagF capsular polysaccharide capsule enzymatic synthesis nuclear magnetic resonance polymerases Microbiology QR1-502 |
spellingShingle |
TagF capsular polysaccharide capsule enzymatic synthesis nuclear magnetic resonance polymerases Microbiology QR1-502 Christa Litschko Davide Oldrini Insa Budde Monika Berger Jochen Meens Rita Gerardy-Schahn Francesco Berti Mario Schubert Timm Fiebig A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens |
description |
ABSTRACT Group 2 capsule polymers represent crucial virulence factors of Gram-negative pathogenic bacteria. They are synthesized by enzymes called capsule polymerases. In this report, we describe a new family of polymerases that combine glycosyltransferase and hexose- and polyol-phosphate transferase activity to generate complex poly(oligosaccharide phosphate) and poly(glycosylpolyol phosphate) polymers, the latter of which display similarity to wall teichoic acid (WTA), a cell wall component of Gram-positive bacteria. Using modeling and multiple-sequence alignment, we showed homology between the predicted polymerase domains and WTA type I biosynthesis enzymes, creating a link between Gram-negative and Gram-positive cell wall biosynthesis processes. The polymerases of the new family are highly abundant and found in a variety of capsule-expressing pathogens such as Neisseria meningitidis, Actinobacillus pleuropneumoniae, Haemophilus influenzae, Bibersteinia trehalosi, and Escherichia coli with both human and animal hosts. Five representative candidates were purified, their activities were confirmed using nuclear magnetic resonance (NMR) spectroscopy, and their predicted folds were validated by site-directed mutagenesis. IMPORTANCE Bacterial capsules play an important role in the interaction between a pathogen and the immune system of its host. During the last decade, capsule polymerases have become attractive tools for the production of capsule polymers applied as antigens in glycoconjugate vaccine formulations. Conventional production of glycoconjugate vaccines requires the cultivation of the pathogen and thus the highest biosafety standards, leading to tremendous costs. With regard to animal husbandry, where vaccines could avoid the extensive use of antibiotics, conventional production is not sufficiently cost-effective. In contrast, enzymatic synthesis of capsule polymers is pathogen-free and fast, offers high stereo- and regioselectivity, and works with high efficacy. The new capsule polymerase family described here vastly increases the toolbox of enzymes available for biotechnology purposes. Representatives are abundantly found in human pathogens but also in animal pathogens, paving the way for the exploitation of polymerases for the development of a new generation of vaccines for animal husbandry. |
format |
article |
author |
Christa Litschko Davide Oldrini Insa Budde Monika Berger Jochen Meens Rita Gerardy-Schahn Francesco Berti Mario Schubert Timm Fiebig |
author_facet |
Christa Litschko Davide Oldrini Insa Budde Monika Berger Jochen Meens Rita Gerardy-Schahn Francesco Berti Mario Schubert Timm Fiebig |
author_sort |
Christa Litschko |
title |
A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens |
title_short |
A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens |
title_full |
A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens |
title_fullStr |
A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens |
title_full_unstemmed |
A New Family of Capsule Polymerases Generates Teichoic Acid-Like Capsule Polymers in Gram-Negative Pathogens |
title_sort |
new family of capsule polymerases generates teichoic acid-like capsule polymers in gram-negative pathogens |
publisher |
American Society for Microbiology |
publishDate |
2018 |
url |
https://doaj.org/article/6c00b5c8ad3940f2af66b90fac7376c3 |
work_keys_str_mv |
AT christalitschko anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT davideoldrini anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT insabudde anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT monikaberger anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT jochenmeens anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT ritagerardyschahn anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT francescoberti anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT marioschubert anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT timmfiebig anewfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT christalitschko newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT davideoldrini newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT insabudde newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT monikaberger newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT jochenmeens newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT ritagerardyschahn newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT francescoberti newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT marioschubert newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens AT timmfiebig newfamilyofcapsulepolymerasesgeneratesteichoicacidlikecapsulepolymersingramnegativepathogens |
_version_ |
1718426972486369280 |